Aripiprazol Pliva 10 mg raspadljive tablete za usta Kroatië - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

aripiprazol pliva 10 mg raspadljive tablete za usta

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - aripiprazolum - raspadljiva tableta za usta - 10 mg - urbroj: svaka raspadljiva tableta za usta sadrži 10 mg aripiprazola

Aripiprazol Pliva 15 mg raspadljive tablete za usta Kroatië - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

aripiprazol pliva 15 mg raspadljive tablete za usta

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - aripiprazolum - raspadljiva tableta za usta - 15 mg - urbroj: svaka raspadljiva tableta za usta sadrži 15 mg aripiprazola

Vocabria Europese Unie - Kroatisch - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Clopidogrel Teva Generics B.V. Europese Unie - Kroatisch - EMA (European Medicines Agency)

clopidogrel teva generics b.v.

teva pharma b.v. - clopidogrel (as hydrochloride) - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotska sredstva - Клопидогрел prikazan odrasle za prevenciju атеротромботических događaja:pacijenti koji pate инфарктом miokarda (od nekoliko dana do manje od 35 dana), ishemijski moždani udar (od 7 dana prije manje od 6 mjeseci) ili instaliranim bolest perifernih arterija. patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). porastom segmenta st akutni infarkt miokarda, u kombinaciji s ask u liječenju pacijenata koji imaju pravo na thrombolytic terapije. za više informacija, molimo pogledajte odjeljak 5.

Eucreas Europese Unie - Kroatisch - EMA (European Medicines Agency)

eucreas

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Iasibon Europese Unie - Kroatisch - EMA (European Medicines Agency)

iasibon

pharmathen s.a. - ibandroninska kiselina - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - lijekovi za liječenje bolesti kostiju - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. liječenje tumor-induced гиперкальциемии sa ili bez metastaza. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europese Unie - Kroatisch - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Zomarist Europese Unie - Kroatisch - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Segluromet Europese Unie - Kroatisch - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Eprizet 10 mg/10 mg tablete Kroatië - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

eprizet 10 mg/10 mg tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - rosuvastatinkalcij ezetimib - tableta - 10 mg + 10 mg - urbroj: jedna tableta sadrži 10 mg rosuvastatina (u obliku rosuvastatinkalcija) i 10 mg ezetimiba